BOSTON — Dozens of cardiologists, radiologists, and investors gathered Monday in a hotel conference room to hash out the future of artificial intelligence in medicine.

Questions and uncertainty abounded. How well does artificial intelligence work, compared to fallible human doctors? What is the Food and Drug Administration going to say? And how do artificially intelligent systems make decisions, anyway?

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.